Open Orphan – Upcoming Investor Events July 8, 2020 – Posted in: Open Orphan (ORPH)

8th July, 2020 Open Orphan Plc (“Open Orphan” or the “Company”) Upcoming Investor Events Open Orphan plc (ORPH), a rapidly growing specialist CRO pharmaceutical services company which is the world leader in the testing of vaccines and antivirals using human challenge study models is delighted to be attending and presenting at a series of investor events from the 9th to 11th July 2020. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance for all of…

Continue reading

Open Orphan (ORPH) Upcoming Investor Events September 2, 2019 – Posted in: Open Orphan (ORPH)

Open Orphan, a European-focussed, rare and orphan drug consulting services platform, is pleased to announce that the Company will be attending and presenting at a series of investor events from the 4thSeptember to 10th October 2019. Cathal Friel, Open Orphan’s Chief Executive Officer, will be in attendance for all of the events and will be presenting to update existing and potential investors on the Company’s business plans for 2019-2020. No new material information will be disclosed…

Continue reading